Optimi Health Corp. is a Canadian-based pharmaceutical and life sciences company specializing in the research, cultivation, and manufacturing of controlled substances and functional mushrooms. Headquartered in Vancouver, the company operates a sophisticated, large-scale production facility in Princeton, British Columbia, which is Health Canada-licensed and GMP-compliant. Optimi Health is positioned as a vertically integrated provider in the emerging psychedelic therapy industry. The company focuses on producing high-quality, standardized psilocybin and MDMA for use in clinical trials and authorized therapeutic applications. Their facility is designed to meet the rigorous standards required for pharmaceutical supply chains, aiming to become a primary global supplier as regulatory frameworks for psychedelic medicine evolve. In addition to its controlled substances division, Optimi Health produces a range of functional mushroom supplements—including Lion's Mane, Reishi, and Cordyceps—targeted at the health and wellness consumer market. By combining advanced indoor growing technology with scientific research, the company seeks to validate the therapeutic benefits of fungi and provide safe, scalable solutions for mental health and physical performance. The company's strategy involves securing international export permits and establishing strategic partnerships with research institutions and healthcare providers worldwide.